These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18723439)

  • 1. Alpha1-antitrypsin inhibits the activity of the matriptase catalytic domain in vitro.
    Janciauskiene S; Nita I; Subramaniyam D; Li Q; Lancaster JR; Matalon S
    Am J Respir Cell Mol Biol; 2008 Dec; 39(6):631-7. PubMed ID: 18723439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1.
    Tseng IC; Chou FP; Su SF; Oberst M; Madayiputhiya N; Lee MS; Wang JK; Sloane DE; Johnson M; Lin CY
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C423-31. PubMed ID: 18550704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity.
    Szabo R; Netzel-Arnett S; Hobson JP; Antalis TM; Bugge TH
    Biochem J; 2005 Aug; 390(Pt 1):231-42. PubMed ID: 15853774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity.
    Krotova K; Marek GW; Wang RL; Aslanidi G; Hoffman BE; Khodayari N; Rouhani FN; Brantly ML
    Am J Respir Cell Mol Biol; 2017 Aug; 57(2):238-247. PubMed ID: 28362108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of a type II transmembrane serine protease, matriptase, is dependent solely on the catalytic domain.
    Kojima K; Tsuzuki S; Fushiki T; Inouye K
    Biosci Biotechnol Biochem; 2009 Feb; 73(2):454-6. PubMed ID: 19202271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reverse binding motif that contributes to specific protease inhibition by antibodies.
    Schneider EL; Lee MS; Baharuddin A; Goetz DH; Farady CJ; Ward M; Wang CI; Craik CS
    J Mol Biol; 2012 Jan; 415(4):699-715. PubMed ID: 22154938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins.
    Velasco G; Cal S; Quesada V; Sánchez LM; López-Otín C
    J Biol Chem; 2002 Oct; 277(40):37637-46. PubMed ID: 12149247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase.
    Kojima K; Tsuzuki S; Fushiki T; Inouye K
    J Biol Chem; 2008 Feb; 283(5):2478-87. PubMed ID: 18048349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of catalytic domain of Matriptase in complex with Sunflower trypsin inhibitor-1.
    Yuan C; Chen L; Meehan EJ; Daly N; Craik DJ; Huang M; Ngo JC
    BMC Struct Biol; 2011 Jun; 11():30. PubMed ID: 21693064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of O-(3-carbamimidoylphenyl)-l-serine amides as matriptase inhibitors using a fragment-linking approach.
    Goswami R; Wohlfahrt G; Mukherjee S; Ghadiyaram C; Nagaraj J; Satyam LK; Subbarao K; Gopinath S; Krishnamurthy NR; Subramanya HS; Ramachandra M
    Bioorg Med Chem Lett; 2015 Feb; 25(3):616-20. PubMed ID: 25556099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors.
    Tamberg T; Hong Z; De Schepper D; Skovbjerg S; Dupont DM; Vitved L; Schar CR; Skjoedt K; Vogel LK; Jensen JK
    J Biol Chem; 2019 Jan; 294(1):314-326. PubMed ID: 30409910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of membrane-type serine protease 1/matriptase by natural and synthetic protease inhibitors.
    Yamasaki Y; Satomi S; Murai N; Tsuzuki S; Fushiki T
    J Nutr Sci Vitaminol (Tokyo); 2003 Feb; 49(1):27-32. PubMed ID: 12882393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the matriptase second CUB domain as the secondary site for interaction with hepatocyte growth factor activator inhibitor type-1.
    Inouye K; Tsuzuki S; Yasumoto M; Kojima K; Mochida S; Fushiki T
    J Biol Chem; 2010 Oct; 285(43):33394-33403. PubMed ID: 20682770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface.
    Stirnberg M; Maurer E; Horstmeyer A; Kolp S; Frank S; Bald T; Arenz K; Janzer A; Prager K; Wunderlich P; Walter J; Gütschow M
    Biochem J; 2010 Aug; 430(1):87-95. PubMed ID: 20518742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the stem domain of matriptase in the interaction with its physiological inhibitor, hepatocyte growth factor activator inhibitor type I.
    Kojima K; Tsuzuki S; Fushiki T; Inouye K
    J Biochem; 2009 Jun; 145(6):783-90. PubMed ID: 19276202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the first low-molecular-weight inhibitors of matriptase-2.
    Sisay MT; Steinmetzer T; Stirnberg M; Maurer E; Hammami M; Bajorath J; Gütschow M
    J Med Chem; 2010 Aug; 53(15):5523-35. PubMed ID: 20684597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues.
    Hooper JD; Campagnolo L; Goodarzi G; Truong TN; Stuhlmann H; Quigley JP
    Biochem J; 2003 Aug; 373(Pt 3):689-702. PubMed ID: 12744720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor.
    Oberst MD; Williams CA; Dickson RB; Johnson MD; Lin CY
    J Biol Chem; 2003 Jul; 278(29):26773-9. PubMed ID: 12738778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
    Whisstock J; Lesk AM; Carrell R
    Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does heart surgery change the capacity of α1-antitrypsin to inhibit the ATP-induced release of monocytic interleukin-1β? A preliminary study.
    Agné A; Richter K; Tumpara S; Sauer AL; Beckert F; Wrenger S; Zakrzewicz A; Hecker A; Markmann M; Koch C; Zajonz T; Sander M; Böning A; Padberg W; Janciauskiene S; Grau V
    Int Immunopharmacol; 2020 Apr; 81():106297. PubMed ID: 32062078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.